Successful treatment of pulmonary mucormycosis in a renal transplant recipient with limited pulmonary reserve by combined medical and surgical therapy.

Abstract	Mucormycosis is a rare opportunistic fungal infection in renal transplant recipients which is associated with exceedingly high mortality when inadequately treated. Risk factors for this infection include diabetes, neutropaenia and immunosuppression. We report a case of pulmonary mucormycosis in a renal allograft recipient with type 2 diabetes and limited pulmonary reserve. The patient was successfully treated with lobectomy and liposomal amphotericin B with preservation of pulmonary and allograft functions. Early recognition of this infection is warranted before dissemination, which carries a poor prognosis.
Authors	Jordan Y Z Li, Tuck Y Yong, Craig A Jurisevic, Graeme R Russ, David I Grove, P Toby H Coates, Alex P S Disney
Journal	Heart, lung & circulation (Heart Lung Circ) Vol. 18 Issue 3 Pg. 226-8 (Jun 2009) ISSN: 1444-2892 [Electronic] Australia
PMID	18296117 (Publication Type: Journal Article)
Chemical References	Antifungal Agents
Topics	Antifungal Agents (therapeutic use) Female Humans Immunocompromised Host Kidney Transplantation (immunology) Lung Diseases, Fungal (drug therapy, immunology, surgery) Middle Aged Mucormycosis (drug therapy, immunology, surgery) Pneumonectomy Recovery of Function

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!